Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Pyrexia, SARS-CoV-2 test
Clinical narrative: Bed ridden over 55 hours; weakness; severe headache; fever 48 hours 99.9-101.9; Sweating; severe muscle pain; joint pain- especially in hands; severe chills; chest ache; congestion; brain fog; slight cough; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 16:15 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Sinusitis" (unspecified if ongoing); "asthma" (unspecified if ongoing); "bad allergies" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. The patient took concomitant medications. Past drug history included: Amoxicillin, reaction(s): "Known allergies: Amoxicillin"; Clindymicin, reaction(s): "known allergies: clindymicin(sp?)". Vaccination history included: Covid-19 vaccine (Dose 3 (Booster), single, Unknown Manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, single, Unknown Manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 1, single, Unknown Manufacturer), for COVID-19 immunization. The following information was reported: BEDRIDDEN (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "Bed ridden over 55 hours"; HYPERHIDROSIS (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "Sweating"; FEELING ABNORMAL (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "brain fog"; CHEST PAIN (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "chest ache"; NASAL CONGESTION (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "congestion"; PYREXIA (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "fever 48 hours 99.9-101.9"; ARTHRALGIA (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "joint pain- especially in hands"; CHILLS (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "severe chills"; HEADACHE (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "severe headache"; MYALGIA (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "severe muscle pain"; COUGH (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "slight cough"; ASTHENIA (non-serious) with onset 21Oct2022 at 17:00, outcome "recovering", described as "weakness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of bedridden, asthenia, headache, pyrexia, hyperhidrosis, myalgia, arthralgia, chills, chest pain, nasal congestion, feeling abnormal, cough.  Additional information: Patient received other vaccine on same date 21Oct2022 on Upper right arm as a vaccine location. Patient visited Pharmacy or Drug Store as a facility for administration of COVID-19 vaccine. Patient received no other vaccines within 4 weeks PRIOR to the COVID-19 vaccine. Patient received other medications in two weeks. Prior to vaccination, the patient was diagnosed with COVID.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.